Tyrus Capital S.A.M.’s Atea Pharmaceuticals AVIR Stock Holding History

Tyrus Capital S.A.M.’s Portfolio AVIR Stock Details AVIR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$3.78M	Hold
2023 Q2	$4.71M	Hold
2023 Q1	$4.22M	Hold
2022 Q4	$6.06M	Buy